$AGYS

AGILYSYS INC

CIK:0000078749|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Net revenue:
Total net revenue	$ 87,677	$ 76,675
Cost of goods sold:
Total cost of goods sold	32,020	29,381
Gross profit	$ 55,657	$ 47,294
Gross profit margin	63.50%	61.70%
Operating expenses:
Product development	$ 20,245	$ 17,454
Sales and marketing	12,195	11,793
General and administrative	11,111	10,755
Depreciation of fixed assets	826	944
Amortization of internal-use software and intangibles	1,427	1,457
Other charges, net	115	256
Legal settlements, net	0	114
Total operating expense	45,919	42,773
Operating income	9,738	4,521
Other income (expense):
Interest income	990	447
Interest expense	(70)	(217)
Other income (expense), net	153	98
Income before taxes	10,811	4,849
Income tax provision (benefit)	1,819	(41)
Net income	$ 8,992	$ 4,890
Weighted average shares outstanding - basic	28,102	27,794
Net Income per share - basic:	$ 0.32	$ 0.18
Weighted average shares outstanding - diluted	28,420	28,289
Net Income per share - diluted:	$ 0.32	$ 0.17
Subscription and maintenance [Member]
Net revenue:
Total net revenue	$ 57,742	$ 48,623
Cost of goods sold:
Total cost of goods sold	12,726	9,983
Professional services [Member]
Net revenue:
Total net revenue	19,593	18,098
Cost of goods sold:
Total cost of goods sold	12,661	13,199
Products [Member]
Net revenue:
Total net revenue	10,342	9,954
Cost of goods sold:
Total cost of goods sold	$ 6,633	$ 6,199

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities
Net income	$ 8,992	$ 4,890
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation of fixed assets	826	944
Amortization of internal-use software and intangibles	1,427	1,457
Amortization of developed technology acquired	166	166
Deferred income taxes	1,291	(556)
Share-based compensation	5,988	5,029
Changes in operating assets and liabilities	(10,857)	(16,276)
Net cash provided by (used in) operating activities	7,833	(4,346)
Investing activities
Capital expenditures	(520)	(633)
Net cash used in investing activities	(520)	(633)
Financing activities
Debt repayments	0	(12,000)
Repurchase of common shares to satisfy employee tax withholding	(419)	(924)
Net cash used in financing activities	(419)	(12,924)
Effect of exchange rate changes on cash	(79)	426
Net increase (decrease) in cash and cash equivalents	6,815	(17,477)
Cash and cash equivalents at beginning of period	116,894	73,041
Cash and cash equivalents at end of period	$ 123,709	$ 55,564

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Mar. 31, 2026
Current assets:
Cash and cash equivalents	$ 123,709	$ 116,894
Accounts receivable, net of allowance for expected credit losses of $777 and $1,105, respectively	36,648	43,069
Contract assets	4,663	4,438
Inventories	7,929	7,529
Prepaid expenses and other current assets	9,448	12,201
Total current assets	182,397	184,131
Property and equipment, net	13,374	13,950
Operating lease right-of-use assets	13,398	13,823
Goodwill	131,553	133,908
Intangible assets, net	63,795	66,359
Deferred income taxes, non-current	56,748	58,069
Other non-current assets	11,580	11,288
Total assets	472,845	481,528
Current liabilities:
Accounts payable	12,634	12,445
Contract liabilities	72,867	83,009
Accrued liabilities	13,961	24,333
Operating lease liabilities, current	5,318	5,323
Total current liabilities	104,780	125,110
Deferred income taxes, non-current	9,935	10,144
Operating lease liabilities, non-current	13,125	13,721
Other non-current liabilities	6,678	5,762
Commitments and contingencies
Shareholders' equity:
Common shares, without par value, at $0.30 stated value; 80,000,000 shares authorized; 33,342,288 shares issued; and 28,195,588 and 28,166,478 shares outstanding at June 30, 2026 and March 31, 2026, respectively	10,003	10,003
Treasury shares, 5,146,730 and 5,175,840 at June 30, 2026 and March 31, 2026, respectively	(1,545)	(1,554)
Capital in excess of stated value	137,594	131,632
Retained earnings	208,763	199,771
Accumulated other comprehensive loss	(16,488)	(13,061)
Total shareholders' equity	338,327	326,791
Total liabilities and shareholders' equity	$ 472,845	$ 481,528